GGC4H: Guiding Good Choices for Health
Study Details
Study Description
Brief Summary
This study evaluates the feasibility and effectiveness of implementing Guiding Good Choices (GGC), an anticipatory guidance curriculum for parents of early adolescents, in three large, integrated healthcare systems. By "parents," the study team is referring here and throughout this protocol to those adults who are the primary caregivers of children, irrespective of their biological relationship to the child. In prior community trials, GGC has been shown to prevent adolescent substance use (alcohol, tobacco, and marijuana), depressive symptoms, and delinquent behavior. This study offers an opportunity to test GGC effectiveness with respect to improving adolescent behavioral health outcomes when implemented at scale in pediatric primary care within a pragmatic trial.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 3 |
Detailed Description
Fifty percent of all adolescents will use some form of illicit drugs before the end of high school, 20-25% will meet criteria for depression, and many others will engage in health compromising behaviors like delinquency and violence-with consequences for their long-term health. Evidence-based parenting interventions shown to prevent these behavioral health concerns could improve adolescent health trajectories if implemented widely in pediatric primary care. The American Academy of Pediatrics' Bright Futures recommends that pediatricians offer developmentally tailored anticipatory guidance to all parents to support their children's healthy development, but programs providing guidance are not offered universally.
This study tests the feasibility and effectiveness of implementing Guiding Good Choices, a universal, evidence-based anticipatory guidance curriculum for parents of early adolescents, in three large, integrated healthcare systems serving socioeconomically diverse families. This intervention reduced adolescent alcohol, tobacco and marijuana use, depression, and delinquent behavior in two previous randomized controlled trials. It also strengthened parenting practices and parent-adolescent relationship quality, both broadly protective against behavioral health concerns. Guiding Good Choices has the capacity to achieve population-level impact on adolescent health if made widely available through pediatric primary care. Parents trust pediatricians' advice regarding their children's well-being, and current research with socioeconomically diverse groups suggests that they are eager to participate in family-focused programs offered in primary care clinics.
Building on this body of research, the investigative team, in close cooperation with the NIH Healthcare Systems Research Collaboratory and healthcare systems partners, will conduct a cluster-randomized trial of Guiding Good Choices in 72 pediatric primary care practices, across three heterogeneous health care systems (HCS). Half of the pediatricians will be randomly assigned to the intervention arm, and half will serve as usual care controls. Using a workflow that is easy to adopt, implement and maintain, at each adolescent's 12-year-old well visit, primary care pediatricians will recommend that parents enroll in the intervention. Over 3,600 families are expected to be recruited into the trial prior to beginning intervention with them. Half will be recruited in year 2 and half in year 3.
The team will use the Reach, Effectiveness, Adoption, Implementation, and Maintenance, or RE-AIM, framework to test implementation outcomes and effectiveness, including hypothesized reductions in the study's primary outcome of substance use initiation, several secondary behavioral health problems (e.g., substance use frequency, mood symptoms and diagnoses, delinquency) and some exploratory outcomes (e.g., emergency department and inpatient service utilization) among adolescents in the intervention arm compared to those in the control arm. Data from an Adolescent Behavioral Health Survey and electronic healthcare records will be used to monitor outcomes up to 3 years post intervention. The feasibility and sustainability of implementing the intervention in each HCS, including health economic evaluation to understand costs in relation to value gained, will also be assessed.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Guiding Good Choices Enrollment in the intervention, Guiding Good Choices, a substance use initiation prevention program, will be recommended by the pediatrician to parents of those adolescents empaneled with an intervention arm pediatrician |
Behavioral: Guiding Good Choices
Guiding Good Choices is a 5-session group-based prevention program for parents of early adolescents. Weekly 2.5 hour sessions will be held at participants' primary care clinics and led by two trained interventionists. Through didactic material, video segments, interactive activities, and home practice, the curriculum teaches parents to understand the progression from individual and environmental risk and protective factors to substance use and problem behavior, enhances parenting behaviors and skills, teaches effective family management skills, strengthens parent-adolescent interactions and bonding, broadens opportunities for family involvement, teaches conflict reduction and anger management skills, and teaches adolescents skills to resist peer influences to engage in risky behavior. Parents who opt not to attend groups will be offered a self-guided intervention manual containing the same core content and video access, plus supportive coaching to motivate use and address questions.
Other Names:
|
| No Intervention: Control Parents of adolescents empaneled with a control arm pediatrician will not be offered Guiding Good Choices |
Outcome Measures
Primary Outcome Measures
- Incidence of adolescent substance use initiation (alcohol, cigarettes, e-cigarettes, and/or marijuana) through last follow-up [Final follow-up in year 5 of study]
Substance use initiation by the study's endpoint will be operationalized by a dichotomous indicator of ever use (yes/no) of alcohol, cigarettes, e-cigarettes, or marijuana formed from adolescent prospective self-reports about their lifetime use of these substances in each data collection wave. Substances will be assessed by separate items, e.g., "Have you ever used marijuana (by used we mean smoked, vaped, eaten, etc.)," "Have you ever used an e-cigarette or vaped ("Juul," "e-hookah," etc.)?" Lifetime use by last follow-up will be indicated by reported use of any of the substances in any wave. Lack of use will be indicated by no reported use of any of the substances in all waves.
Secondary Outcome Measures
- Prevalence of any past-year substance use (alcohol, cigarettes, e-cigarettes, marijuana) by adolescents at final follow-up [3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments]
Past-year substance use at the study's endpoint will be assessed by a dichotomous indicator of past-year use (yes/no) of alcohol, cigarettes, e-cigarettes, or marijuana formed from separate items asking participants to report how many times in the past year they have used alcohol, cigarettes, e-cigarettes, and marijuana (e.g., "How many times in the past year have you used marijuana?"). Past-year use will be indicated by use of at least one of the substances at least once in the past year. No past-year use will be indicated by no reported use of any of the four substances in the past year.
- Prevalence of any past-30-day substance use (alcohol, cigarettes, e-cigarettes, marijuana) by adolescents at final follow-up [3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments]
Past-30-day substance use at the study endpoint will be assessed by a dichotomous indicator of past-30-day use (yes/no) of alcohol, cigarettes, e-cigarettes, or marijuana formed from separate items asking participants to report how many times in the past month they have used alcohol, cigarettes, e-cigarettes, and marijuana (e.g., "On how many days (if any) have you used marijuana in the past 30 days?"). Past-30-day use will be indicated by use of at least one of the substances on at least one day in the past 30 days. No past-30-day use will be indicated by no reported use of any of the four substances in the past 30 days.
- Incidence of antisocial behavior among adolescents through final follow-up [3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments]
Self-reported antisocial behavior by the study's endpoint will be assessed by a dichotomous indicator of lifetime participation in any antisocial behavior, measured by adolescent prospective reports at each wave of their participation in 7 behaviors (e.g., been suspended from school, stolen something worth more than $5, been arrested), each measured by a different item. Baseline assessment will ask participants whether they ever participated in these behaviors; subsequent assessments will ask about past-year participation. Lifetime antisocial behavior will be indicated by reported engagement in any of the 7 behaviors in any wave. Lack of antisocial behavior will be indicated by no engagement in any of the 7 behaviors in all waves.
- Mean adolescent depression symptom score at final follow-up [3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments]
Self-reports of depressive symptoms at the study endpoint will be assessed via the PHQ-9. This 9-item scale asks respondents to report on their depressive symptoms over the past 2 weeks (e.g., feeling down, depressed, irritable, or hopeless; feeling tired or having energy). Each item is scored 0=Not at all, 1=Several days, 2=More than half the days, 4=Nearly every day, yielding a total score between 0 and 36.
- Mean adolescent anxiety symptom score at final follow-up [3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments]
Self-reports of anxiety symptoms at the study endpoint will be assessed via the GAD-7, a 7-item scale that asks respondents to report on their anxiety symptoms over the past 2 weeks (e.g., feeling nervous, anxious or on edge; Trouble relaxing). Each of the 7 items is scored 0=Not at all, 1=Several days, 2=More than half the days, 4=Nearly every day, yielding a total score between 0 and 28.
- Prevalence of past-year antisocial behavior among adolescents at final follow-up [3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments]
Self-reported antisocial behavior at the study endpoint will be assessed by adolescent reports of their past-year participation in 7 behaviors (e.g., been suspended from school, stolen something worth more than $5, been arrested), each measured by a different item. Past-year antisocial behavior will be indicated by reported engagement in any of the 7 behaviors in any wave. Lack of past-year antisocial behavior will be indicated by no engagement in any of the 7 behaviors in the past year.
Other Outcome Measures
- Prevalence of substance use disorders among adolescents through final extraction [3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments]
ICD-10 substance use disorder diagnoses recorded in the EHR through final data extraction. Any substance use disorder will be summarized at 12-month intervals beginning at baseline, through last extraction.
- Prevalence of any psychiatric disorder (depression, anxiety, or conduct disorder) among adolescents through final extraction [3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments]
ICD-10 depression, anxiety, and conduct disorder diagnoses recorded in the EHR through final data extraction. Any substance use disorder will be summarized at 12-month intervals beginning at baseline, through last extraction.
- Prevalence of specialty substance use treatment services utilization by adolescents through final extraction [3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments]
Specialty substance use treatment services utilization data extracted from the EHR. Any utilization will be summarized at 12-month intervals beginning at baseline, through study endpoint.
- Prevalence of specialty mental health services utilization by adolescents through final extraction [3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments]
Specialty mental health services utilization data extracted from the EHR. Any utilization will be summarized at 12-month intervals beginning at baseline, through study endpoint.
- Prevalence of emergency department utilization by adolescents through final extraction [3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments]
Automated emergency department utilization data extracted from the EHR. Any utilization will be summarized at 12-month intervals beginning at baseline, through study endpoint.
- Prevalence of inpatient hospitalization utilization by adolescents through final extraction [3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments]
Automated inpatient hospitalization utilization data extracted from the EHR. Any utilization will be summarized at 12-month intervals beginning at baseline, through study endpoint.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Adolescent is empaneled with an intervention or control arm pediatrician in a participating clinic in one of the three healthcare systems (Kaiser Permanente Northern California, Kaiser Permanente Colorado, Henry Ford Health System)
-
Adolescent is 12.00 - 12.99 years during intervention period (born between 6.1.2007 and 5.31.2009), which means that some adolescents may be 11 at baseline assessment
Exclusion Criteria:
-
An intellectual, developmental or cognitive impairment that would prevent parent or adolescent from understanding the purpose of the study and measures, or, for those in the intervention arm, the Guiding Good Choices curriculum. For adolescents, exclusions will be operationalized by specific ICD-9/ICD-10 diagnostic codes documented in the EHR. For parents, impairment will be identified at the discretion of the pediatrician referring GGC or by study team members making study recruitment and intervention enrollment calls to parents.
-
Parent's primary language is not English, as documented in the EHR or identified at study recruitment call
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Kaiser Permanente Northern California | Oakland | California | United States | 94612 |
| 2 | Kaiser Permanente Colorado | Aurora | Colorado | United States | 80014 |
| 3 | Henry Ford Health System | Detroit | Michigan | United States | 48202 |
Sponsors and Collaborators
- University of Washington
- Kaiser Permanente
- Henry Ford Health System
- National Center for Complementary and Integrative Health (NCCIH)
Investigators
- Principal Investigator: Margaret R Kuklinski, PhD, University of Washington
- Principal Investigator: Richard F Catalano, PhD, University of Washington
- Principal Investigator: Stacy A Sterling, DrPH, Kaiser Permanente
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- SITE00000037
- 4UH3AT009838